231 related articles for article (PubMed ID: 26033451)
21. Fluorescence-guided assessment of bone and soft-tissue sarcomas for predicting the efficacy of telomerase-specific oncolytic adenovirus.
Uotani K; Tazawa H; Hasei J; Fujiwara T; Yoshida A; Yamakawa Y; Omori T; Sugiu K; Komatsubara T; Kondo H; Morita T; Kiyono M; Yokoo S; Hata T; Kunisada T; Takeda K; Urata Y; Fujiwara T; Ozaki T
PLoS One; 2024; 19(2):e0298292. PubMed ID: 38377118
[TBL] [Abstract][Full Text] [Related]
22. Fluorescence-guided surgery of human colon cancer increases complete resection resulting in cures in an orthotopic nude mouse model.
Metildi CA; Kaushal S; Snyder CS; Hoffman RM; Bouvet M
J Surg Res; 2013 Jan; 179(1):87-93. PubMed ID: 23079571
[TBL] [Abstract][Full Text] [Related]
23. Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.
Hiroshima Y; Lwin TM; Murakami T; Mawy AA; Kuniya T; Chishima T; Endo I; Clary BM; Hoffman RM; Bouvet M
J Surg Oncol; 2016 Dec; 114(8):951-958. PubMed ID: 27696448
[TBL] [Abstract][Full Text] [Related]
24. Fluorescence-guided surgery improves outcome in an orthotopic osteosarcoma nude-mouse model.
Miwa S; Hiroshima Y; Yano S; Zhang Y; Matsumoto Y; Uehara F; Yamamoto M; Kimura H; Hayashi K; Bouvet M; Tsuchiya H; Hoffman RM
J Orthop Res; 2014 Dec; 32(12):1596-601. PubMed ID: 25138581
[TBL] [Abstract][Full Text] [Related]
25. Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice.
Hiroshima Y; Maawy A; Sato S; Murakami T; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
J Surg Res; 2014 Apr; 187(2):510-7. PubMed ID: 24373959
[TBL] [Abstract][Full Text] [Related]
26. Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug Screening.
Kiyuna T; Murakami T; Tome Y; Igarashi K; Kawaguchi K; Russell T; Eckardt MA; Crompton J; Singh A; Bernthal N; Bukata S; Federman N; Kanaya F; Eilber FC; Hoffman RM
J Cell Biochem; 2017 Feb; 118(2):361-365. PubMed ID: 27357060
[TBL] [Abstract][Full Text] [Related]
27. A Mouse Model of Fluorescent Protein-expressing Disseminated Peritoneal Lymphoma for Fluorescence-guided Surgery.
Matsumoto T; Suetsugu A; Hasegawa K; Nakamura M; Shibata Y; Aoki H; Kunisada T; Tsurumi H; Shimizu M; Bouvet M; Hoffman RM
Anticancer Res; 2016 Sep; 36(9):4483-7. PubMed ID: 27630285
[TBL] [Abstract][Full Text] [Related]
28. OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro.
Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Cancer Gene Ther; 2017 Feb; 24(2):45-47. PubMed ID: 28106046
[TBL] [Abstract][Full Text] [Related]
29. Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expression.
Omori T; Tazawa H; Yamakawa Y; Osaki S; Hasei J; Sugiu K; Komatsubara T; Fujiwara T; Yoshida A; Kunisada T; Urata Y; Kagawa S; Ozaki T; Fujiwara T
PLoS One; 2021; 16(4):e0250643. PubMed ID: 33886686
[TBL] [Abstract][Full Text] [Related]
30. Tumor-targeting adenovirus OBP-401 inhibits primary and metastatic tumor growth of triple-negative breast cancer in orthotopic nude-mouse models.
Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Oncotarget; 2016 Dec; 7(51):85273-85282. PubMed ID: 27863373
[TBL] [Abstract][Full Text] [Related]
31. In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation.
Kishimoto H; Zhao M; Hayashi K; Urata Y; Tanaka N; Fujiwara T; Penman S; Hoffman RM
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14514-7. PubMed ID: 19706537
[TBL] [Abstract][Full Text] [Related]
32. Imaging the microenvironment of pancreatic cancer patient-derived orthotopic xenografts (PDOX) growing in transgenic nude mice expressing GFP, RFP, or CFP.
Hoffman RM; Bouvet M
Cancer Lett; 2016 Sep; 380(1):349-55. PubMed ID: 26742463
[TBL] [Abstract][Full Text] [Related]
33. Selective metastatic tumor labeling with green fluorescent protein and killing by systemic administration of telomerase-dependent adenoviruses.
Kishimoto H; Urata Y; Tanaka N; Fujiwara T; Hoffman RM
Mol Cancer Ther; 2009 Nov; 8(11):3001-8. PubMed ID: 19887549
[TBL] [Abstract][Full Text] [Related]
34. Color-coded Imaging Enables Fluorescence-guided Surgery to Resect the Tumor Along with the Tumor Microenvironment in a Syngeneic Mouse Model of EL-4 Lymphoma.
Hasegawa K; Suetsugu A; Nakamura M; Matsumoto T; Kunisada T; Shimizu M; Saji S; Moriwaki H; Bouvet M; Hoffman RM
Anticancer Res; 2016 Sep; 36(9):4443-8. PubMed ID: 27630280
[TBL] [Abstract][Full Text] [Related]
35. Dual-color imaging of angiogenesis and its inhibition in bone and soft tissue sarcoma.
Hayashi K; Yamauchi K; Yamamoto N; Tsuchiya H; Tomita K; Amoh Y; Hoffman RM; Bouvet M
J Surg Res; 2007 Jun; 140(2):165-70. PubMed ID: 17418866
[TBL] [Abstract][Full Text] [Related]
36. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
[TBL] [Abstract][Full Text] [Related]
37. Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC).
Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
Pancreatology; 2015; 15(3):295-301. PubMed ID: 25800176
[TBL] [Abstract][Full Text] [Related]
38. Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination.
Takakura M; Nakamura M; Kyo S; Hashimoto M; Mori N; Ikoma T; Mizumoto Y; Fujiwara T; Urata Y; Inoue M
Cancer Gene Ther; 2010 Jan; 17(1):11-9. PubMed ID: 19662088
[TBL] [Abstract][Full Text] [Related]
39. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T
Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494
[TBL] [Abstract][Full Text] [Related]
40. Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.
Fujiwara T; Kagawa S; Kishimoto H; Endo Y; Hioki M; Ikeda Y; Sakai R; Urata Y; Tanaka N; Fujiwara T
Int J Cancer; 2006 Jul; 119(2):432-40. PubMed ID: 16477640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]